The #FDA released a statement today ALERTING laboratory personnel and healthcare providers about #Illumina cybersecurity vulnerabilities. Illumina supplies the majority of genomic laboratories with instrumentation to sequence DNA. The letter to healthcare providers...
FDA Safety Communication for Patients and Healthcare Providers on NIPS
--------------- FDA WARNING to patients and healthcare providers published yesterday! Non-invasive prenatal screening (NIPS, also referred to as NIPT) is widely used but โnone have yet been authorized, cleared, or approved by the FDA. The accuracy and performance of...
FDA Control of Laboratory Developed Tests (LDTs) Building Momentum with VALID Act
--------------- ๐๐๐ ๐ข๐ฉ๐๐ฅ๐ฆ๐๐๐๐ง ๐ก๐๐๐๐๐ ๐ฆ๐ข ๐๐๐ ๐ง๐๐ฆ๐ง๐ฆ ๐๐ข ๐ ๐ข๐ฅ๐ ๐๐ข๐ข๐ ๐ง๐๐๐ก ๐๐๐ฅ๐ ๐๐ก๐ Center for Genomic Interpretation (CGI) ๐ฌ๐ฎ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ญ๐ก๐ ๐ฉ๐๐๐๐ (๐ฉ๐ฒ๐ฟ๐ถ๐ณ๐๐ถ๐ป๐ด ๐๐ฐ๐ฐ๐๐ฟ๐ฎ๐๐ฒ, ๐๐ฒ๐ฎ๐ฑ๐ถ๐ป๐ด-๐ฒ๐ฑ๐ด๐ฒ ๐๐ฉ๐๐ง ๐๐ฒ๐๐ฒ๐น๐ผ๐ฝ๐บ๐ฒ๐ป๐) ๐๐ฐ๐. This bill was introduced in Congress in December 2018, but is picking...
Natera and CareDx Fined Millions for False Advertising Associated with Inappropriate Marketing for Testing
--------------- Genetic and genomic testing is NOT regulated by the FDA. Whether your patients or loved ones are being tested for cancer, prenatal testing, rare diseases, etc., a Laboratory Developed Test (LDT), which 99% of genetic and genomic tests are today,...
Natera Minimal Residual Disease (MRD) Test Value Questioned by City of Hope for Colorectal Cancer Patients
--------------- โResearchers at City of Hope question the reliability and utility of Nateraโs Signatera, highlighting the results as evidence that genomic minimal residual disease (MRD) testing may be at BEST unhelpful and at WORST unreliable in detecting recurrences...